Shintani, Terumichi <br/><br/>
The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.  [electronic resource] 

 -  Urology  Mar 2017 
 - 169.e7-169.e13 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/j.urology.2016.12.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anilides--pharmacology<br/>Blotting, Western<br/>Cell Count<br/>Cell Line, Tumor--drug effects<br/>Cell Proliferation--drug effects<br/>Gene Expression Regulation, Neoplastic<br/>Hepatocyte Growth Factor--biosynthesis<br/>Humans<br/>Matrix Metalloproteinase 1--biosynthesis<br/>Neoplasm Invasiveness--genetics<br/>Protein Array Analysis<br/>Proto-Oncogene Proteins c-met--biosynthesis<br/>Pyridines--pharmacology<br/>RNA, Neoplasm--genetics<br/>Receptor Protein-Tyrosine Kinases<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction<br/>Urinary Bladder--drug effects<br/>Urinary Bladder Neoplasms--drug therapy